Related Experiment Video
Updated: Jul 14, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Acetaldehyde, polymorphisms and the cardiovascular system.
Shih-Jiun Yin1, Giia-Sheun Peng
1Department of Biochemistry, National Defense Medical Center, 161 Min-Chuan East Road Section 6, Taipei 114, Taiwan.
Novartis Foundation Symposium
|June 27, 2007
Summary
Genetic variations in alcohol-metabolizing enzymes, specifically ADH1B and ALDH2, offer protection against alcoholism. The ALDH2*2 variant significantly reduces alcoholism risk by causing discomfort from acetaldehyde accumulation.
Area of Science:
- Genetics
- Pharmacology
- Neuroscience
Background:
- Alcoholism vulnerability is influenced by genetic factors.
- Polymorphisms in alcohol-metabolizing enzymes like ADH1B and ALDH2 are key genetic determinants.
- The protective effects of ADH1B*2 and ALDH2*2 alleles against alcoholism are well-established.
Purpose of the Study:
- To investigate the direct correlation between ADH1B*2 genotype and blood acetaldehyde levels.
- To elucidate the mechanisms underlying the protective effects of ALDH2*2/*2 homozygosity and ALDH2*1/*2 heterozygosity against alcoholism.
- To examine the relationship between ALDH2 genotypes, alcohol and acetaldehyde concentrations, physiological responses, and subjective perceptions.
Main Methods:
- Alcohol challenge studies with varying doses (0.2g/kg to 0.5g/kg).
- Measurement of blood ethanol and acetaldehyde concentrations.
- Monitoring of cardiovascular haemodynamic responses and subjective perceptions.
Main Results:
- ALDH2*2/*2 homozygosity confers near-complete protection against alcoholism, likely due to discomfort from elevated acetaldehyde.
- ALDH2*1/*2 heterozygosity provides partial protection, linked to lower acetaldehyde accumulation and reduced adverse reactions.
- Direct correlation between ADH1B*2 and blood acetaldehyde was not verified, unlike ALDH2*2.
Conclusions:
- The ALDH2*2/*2 genotype promotes abstinence or moderation through adverse physiological and psychological responses to acetaldehyde.
- Partial protection by ALDH2*1/*2 is attributed to moderated acetaldehyde levels and associated reactions.
- Genetic variations in alcohol metabolism significantly impact alcoholism risk and consumption behaviors.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:19Aldehydes and Ketones with Alcohols: Hemiacetal Formation
Similar to water, alcohols can add to the carbonyl carbon of the aldehydes and ketones. The addition of one molecule of alcohol to the carbonyl compound forms the hemiacetal or half acetal. As depicted below, in a hemiacetal, the carbon is directly linked to an OH and OR group.